Please check your internet connection and try again.
# Arsil-dx (Typically refers to Dextromethorphan/Chlorpheniramine/Phenylephrine combination)
## Overview
Arsil-dx is a multi-ingredient over-the-counter (OTC) formulation typically containing an antitussive (dextromethorphan), a first-generation antihistamine (chlorpheniramine), and a decongestant (phenylephrine). It is indicated for the temporary relief of symptoms associated with the common cold or upper respiratory allergies.
## Primary Indications
- Temporary relief of cough due to minor throat/bronchial irritation.
- Nasal congestion, sneezing, rhinorrhea, and itchy/watery eyes associated with the common cold or hay fever.
## Adult Dosing
- **Standard Dosing:** 10 mL (or 1 tablet/capsule) orally every 4 to 6 hours as needed.
- **Maximum Dose:** Do not exceed 4 doses (40 mL or 4 doses) in a 24-hour period.
## Pediatric Dosing
- **Children 6 to 12 years:** 5 mL every 4 to 6 hours. Do not exceed 4 doses in 24 hours.
- **Children under 6 years:** Not recommended. OTC cough and cold products are generally contraindicated in young children due to lack of efficacy and risk of serious side effects (e.g., sedation, respiratory distress). Consult a pediatrician for weight-based guidance if necessary.
## Dose Adjustments
- **Renal/Hepatic Impairment:** No specific guidelines; however, use with extreme caution in patients with significant impairment as first-generation antihistamines and phenylephrine may exacerbate underlying cardiovascular or neurological conditions.
- **Geriatric:** Start at the lowest possible dose due to increased risk of anticholinergic side effects (urinary retention, confusion, sedation) and cardiovascular risks.
## Contraindications
- Known hypersensitivity to any component.
- Concurrent use or use within 14 days of Monoamine Oxidase Inhibitors (MAOIs).
- Severe hypertension or ischemic heart disease (due to phenylephrine).
- Narrow-angle glaucoma or symptomatic prostatic hypertrophy (due to chlorpheniramine).
## Adverse Effects
- **CNS:** Drowsiness, dizziness, paradoxical excitation (especially in children).
- **Anticholinergic:** Dry mouth, blurred vision, urinary retention, constipation.
- **Cardiovascular:** Hypertension, tachycardia, palpitations.
## Key Drug Interactions
- **MAOIs:** Risk of hypertensive crisis.
- **CNS Depressants (Alcohol, Benzodiazepines, Opioids):** Synergistic sedation.
- **Antihypertensives:** Phenylephrine may antagonize the therapeutic effect of blood pressure medications.
- **TCAs:** May increase the pressor effects of phenylephrine.
## Monitoring
- Monitor blood pressure if the patient has a history of hypertension.
- Assess for urinary retention, particularly in elderly men.
- Monitor for excessive sedation or altered mental status.
## Clinical Pearls
- **Caffeine content:** Advise patients to limit caffeine intake while taking this medication as it may increase nervousness or tremor.
- **Avoid "Dose Stacking":** Many OTC products contain the same active ingredients; ensure patients are not taking duplicate therapies to prevent toxicity.
- **First-Generation Antihistamines:** Chlorpheniramine frequently causes sedation; patients should be advised not to drive or operate heavy machinery until effects are known.
- **Protocol Variability:** Exact concentrations and dosing frequencies may vary by specific manufacturer formulation. Always verify the concentration (mg/mL) on the specific product label.
***
**Disclaimer:** This information is for educational purposes only. Always verify current prescribing information, patient-specific contraindications, and local institutional protocols before administering any medication. Consult a physician or pharmacist for clinical guidance.